Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Pediatrix Medical Group's average EPS without NRIGrowth Rate was 18.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 7.10% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 9.90% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -8.60% per year.
During the past 13 years, Pediatrix Medical Group's highest 3-Year average EPS without NRI Growth Rate was 101.80% per year. The lowest was -32.40% per year. And the median was 12.50% per year.
Pediatrix Medical Group (FRA:PDC) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Pediatrix Medical Group Earnings per Share (Diluted) Related Terms
Pediatrix Medical Group Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Pediatrix Medical Group's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group Earnings per Share (Diluted) Chart
FRA:PDC vs ADUS, AVAH, SGRY: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's PE Ratio distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's PE Ratio falls into.
Pediatrix Medical Group Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Pediatrix Medical Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of €1.79 mean?
Pediatrix Medical Group (FRA:PDC) has a Earnings per Share (Diluted) of €1.79 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #286 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 56.5%.
Is Pediatrix Medical Group's Earnings per Share (Diluted) too high?
Pediatrix Medical Group's current Earnings per Share (Diluted) is €1.79. Based on the distribution chart, Pediatrix Medical Group ranks #286 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Earnings per Share (Diluted) compare to ADUS and AVAH?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #286 out of 506 companies for Earnings per Share (Diluted). This places Pediatrix Medical Group in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.20, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Earnings per Share (Diluted) is €1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (FRA:PDC) has a current Earnings per Share (Diluted) of €1.79. The stock's GF Value™ is €11.01, compared to a current price of €22.20 — trading 101.6% above its estimated fair value. The current Earnings per Share (Diluted) is €1.79. Pediatrix Medical Group's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Earnings per Share (Diluted) is €1.79 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €22.20 is trading 101.6% above its estimated GF Value™ of €11.01.
Key valuation signals for FRA:PDC:
Earnings per Share (Diluted): €1.79
GF Value™: €11.01 vs. price of €22.20 (101.6% above fair value)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
55GF Score
Get the complete analysis for FRA:PDC
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
